Osteoarthritis Therapeutics and Clinical Aspects

Session Type: ACR Concurrent Abstract Sessions
Tuesday, October 20, 2009: 4:30 PM-6:00 PM
108 B (Pennsylvania Convention Center)
Organizers: Tuhina Neogi, MD, PhD, FRCPC, Boston Univ Schl of Med and Nigel K. Arden, M, Oxford University
Moderators: Timothy McAlindon, MD, MPH, Tufts Medical Center and Ingemar F. Petersson, PhD, Musculoskeletal Research Center
Papers:
4:30 PM
1940
Early Neuromuscular Electrical Stimulation Improves Strength and Functional Performance After Total Knee Arthroplasty
Jennifer E. Stevens-Lapsley, MPT, PhD, University of Colorado Denver; Jaclyn E. Balter, MS, University of Colorado Denver; Wendy M. Kohrt, PhD, University of Colorado Denver; Donald G. Eckhoff, MD, University of Colorado Denver
4:45 PM
1941
Dose-Response Vs Threshold Relationship Between Physical Activity and Function in Knee OA
D. D. Dunlop, PhD, Northwestern University; J. Song, MS, Northwestern University; P. Semanik, Rehabilitation Institute of Chicago; L. Sharma, MD, Northwestern University; R. W. Chang, MD, MPH, Northwestern University
5:00 PM
1942
The Joints On Glucosamine (JOG) Study: A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Structural Benefit of Glucosamine in Knee Osteoarthritis Based On 3T MRI
C. Kent Kwoh, MD, University of Pittsburgh, VA Pittsburgh Healthcare System; Frank W. Roemer, M.D., Boston University School of Medicine; Michael J. Hannon, MA, University of Pittsburgh; Carolyn E. Moore, Texas Woman's University; John M. Jakicic, University of Pittsburgh; Ali Guermazi, M.D., Boston University School of Medicine; Stephanie M. Green, University of Pittsburgh; Robert M. Boudreau, PhD, University of Pittsburgh
5:15 PM
1943
CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results
Kenneth Huttner, M.D., CombinatoRx, Inc.; William J. Shergy, MD, Univ of Alabama; Craig Romney, MD, Liberty Research Center; John C.R. Randle, PhD, CombinatoRx, Inc.
5:30 PM
1944
The Reduction in Serum Level of MMP-3 Seen in a Phase III Study in Knee Osteoarthritis Patients Is Predictive of the Protective Effect On Cartilage Volume Loss of a DMOAD Treatment
Jean-Pierre Pelletier, MD, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital; Jean-Pierre Raynauld, MD, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital; François Abram, PhD, ArthroVision Inc.; Judith Caron, PhD, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital; François Mineau, MSc, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital; B. Haraoui, MD, Institut de Rhumatolgie de Montreal; Denis Choquette, MD, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital; Johanne Martel-Pelletier, PhD, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital
5:45 PM
1945
Higher Subchondral Bone Volume Is Associated with Higher DXA Bone Mineral Density and Knee OA Severity
Grace H. Lo, MD, MSc, Tufts Medical Center; Kimberly Carr, BS, Tufts Medical Center; Lori Lyn Price, MPH, Tufts Medical Center; Erika Schneider, Cleveland Clinic; Sharmila Majumdar, UCSF; Timothy McAlindon, MD, MPH, Tufts Medical Center
See more of: ACR Concurrent Abstract Sessions

To see other sessions for this day, use the date buttons to the left.